Integrase cofactor

Details Integrase cofactor Integrase cofactor

2011-08-30

2011-08-30

Schnizer, Richard (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

08008470

ABSTRACT:
The present invention provides nucleic acid molecules which include a region specifically interacting with the nucleic acid encoding the LEDGF/P75 protein or the nucleic acid encoding a fragment of a LEDGF/P75 protein and methods and uses of such nucleic acid molecules.

REFERENCES:
patent: 5872213 (1999-02-01), Goff
patent: 6222024 (2001-04-01), Goff
patent: 6750052 (2004-06-01), Shinohara et al.
patent: 7326416 (2008-02-01), Kalpana
patent: 2004/0091487 (2004-05-01), Kalpana
patent: 2006/0034860 (2006-02-01), Legrain et al.
patent: 2006/0275748 (2006-12-01), Debyser et al.
patent: 2007/0259358 (2007-11-01), Debyser et al.
patent: WO 95/31904 (1995-11-01), None
patent: WO 99/05278 (1999-02-01), None
patent: WO 00/29578 (2000-05-01), None
Llano (J. Virol. 78(17): 9524-9537, 2004).
Vasquez et al (TIBS 23: 4-9, 1998).
Gryzanov (Biochim. Biophys. Acta 1489:131-140, 1999).
Agrawal et al (Mol. Med. Today 6:72-81, 2000).
Opalinska et al (Nature Reviews Drug Discovery, 2002, vol. 1, pp. 503-514).
Caplen (Expert Opin. Biol. Ther. 2003, vol. 3, pp. 575-586).
Check (Nature, 2003, vol. 425, pp. 10-12).
Scanlon (Curr. Pharm. Biotech. 5:415-420, 2004).
Cejka et al (Clinical Science 110: 47-58, 2006).
Grossman et al (Neuro-Oncology 6: 32-40, 2004).
Nguyen et al (Curr. Opin. Mol. Ther. 10(2): 158-167, 2008).
Moulder et al (Clin. Cancer Res. 14(23): 7909-7916, 2008).
Rudin et al (J. Clin. Oncol.26(6): 870-876, 2008).
Brodin et al., “Disruption of HIV-1 Integrase-DNA Complexes by Short 6-Oxocytosine-Containing Oligonucleotides,”Biochemistry41(5):1529-1538 (2002).
Cherepanov et al., “HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells,”J. Biol. Chem. 278(1):372-381 (2003).
Cherapanov et al., “Solution Structure of the HIV-1 Integrase Binding Domain in LEDGF/p75,”Nat. Struct. Mol. Biol. 12(6):526-532 (2005).
Dietz et al., “The Family of Hepatoma-Derived Growth Factor Proteins: Characterization of a New Member HRP-4 and Classification of its Subfamilies,”Biochem. J. 366(pt. 2):491-500 (2002).
Leh et al., “Determinants of Mg2+-Dependent Activities of Recombinant Human Immunodeficiency Virus Type 1 Integrase,”Biochemistry39(31):9285-9294 (2000).
Merriam-Webster's Online Dictionary, http://www.merriam-webster.com/cgi-bin/dictionary?book=Dictionary&va=analogue, accessed on Jul. 15, 2008; definition of analogue.
Ochs et al., “Autoantibodies to DFS 70 KD/transcription Coactivator p75 in Atopic Dermatitis and Other Conditions,”J. Allergy Clin. Immunol. 105(6 pt. 1):1211-1220 (2000).
Podtelezhnikov et al., “Modeling HIV-1 Integrase Complexes Based on Their Hydrodynamic Properties,”Biopolymers68(1):110-120 (2003).
Rahman et al., “Structure-Based Mutagenesis of the Integrase-LEDGF/p75 Interface Uncouples a Strict Correlation Between In Vitro Protein Binding and HIV-1 Fitness,”Virol. 357(1):79-90 (2007).
Sigma-Aldrich online catalog, <http://www.sigmaaldrich.com/catalog/search/SIRNASearchGeneDetail/101739>, accessed on Jul. 15, 2008.
Vanegas et al., “Identification of the LEDGF/p75 HIV-1 Integrase-Interaction Domain and NLS Reveals NLS-Independent Chromatin Tethering,”J. Cell Sci. 118(pt. 8):1733-1743 (2005).
Van Gent et al., “DNA Binding Properties of the Integrase Proteins of Human Immunodeficiency Viruses Types 1 and 2,”Nucleic Acids Res. 19(14):3821-3827 (1991).
International Search Report for International Application PCT/BE2003/000164, mailed Jul. 1, 2004.
Restriction Requirement for U.S. Appl. No. 10/529,508, mailed Jan. 3, 2007.
Office Action for U.S. Appl. No. 10/529,508, mailed May 31, 2007.
Restriction Requirement for U.S. Appl. No. 11/675,507, mailed Apr. 10, 2008.
Office Action for U.S. Appl. No. 10/529,508, mailed Jun. 26, 2008.
Office Action for U.S. Appl. No. 11/675,507, mailed Aug. 5, 2008.
Notice of Allowance and Notice of Allowability for U.S. Appl. No. 10/529,508, mailed Nov. 25, 2008.

Affiliated with

Also associated with

Rating

Integrase cofactor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrase cofactor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrase cofactor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2621630